Summary & Overview
CPT 93463: Pharmacologic Hemodynamic Monitoring During Inotropic/Vasodilator Therapy
CPT code 93463 describes administration of pharmacologic agents (for example, inhaled nitric oxide or intravenous inotropes such as nitroprusside, dobutamine, or milrinone) with hemodynamic monitoring before, during, and after administration. It is reported in addition to a primary procedure code and captures specialized monitoring and management provided during acute hemodynamic support. Nationally, this code is relevant for hospitals, cardiac catheterization programs, and critical care teams managing patients who require targeted vasoactive or inotropic therapy.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical scope and settings, benchmarking context where available, and policy considerations that affect billing and reporting. The publication covers how 93463 is intended to be used in conjunction with primary procedure codes, typical service locations, and common clinical scenarios that generate the code. Data not available in the input includes specific associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific reimbursement rates. The report is written for a national audience and focuses on practical coding context, payer coverage landscape, and the clinical scenarios that make this add-on monitoring service clinically necessary.
Billing Code Overview
CPT code 93463 describes administration and hemodynamic monitoring associated with pharmacologic agents, such as inhaled nitric oxide or intravenous infusions of nitroprusside, dobutamine, milrinone, or other inotropic agents. The service includes monitoring hemodynamic measurements before, during, and after administration and may include administration of additional hemodynamic agents.
-
Service type: Pharmacologic hemodynamic support with invasive or noninvasive monitoring
-
Typical site of service: Inpatient hospital or intensive care unit; may also occur in cardiac catheterization laboratories or procedural suites where hemodynamic monitoring and agent infusions are performed
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with acute decompensated heart failure is admitted to the cardiac intensive care unit for escalating hemodynamic instability despite optimized medical therapy. The cardiology team places a pulmonary artery (Swan-Ganz) catheter to obtain baseline right- and left-sided filling pressures and cardiac output. The provider initiates a continuous intravenous inotropic infusion (for example, dobutamine or milrinone) and/or a vasodilator (for example, nitroprusside) while continuously monitoring hemodynamics (pulmonary artery pressures, pulmonary capillary wedge pressure, systemic arterial pressure, and cardiac output/index). Hemodynamic measurements are recorded before initiation, at defined intervals during titration, and after dose adjustments. Additional vasoactive agents are added or titrated as needed to achieve target perfusion and filling pressures. The monitoring and pharmacologic management are reported in addition to the primary invasive hemodynamic procedure such as right heart catheterization.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normally assigned services | When the service represents the physician's usual performance of the procedure |
22 | Increased procedural services | When work or complexity is substantially greater than typical for 93463